Page 2 - Juno Diagnostics News Today

Humans continue to evolve with the emergence of new genes

/PRNewswire/ -- Juno Diagnostics™ (JunoDx™), a company focused on bringing vital health information to patients by improving access, affordability, and...

/PRNewswire/ -- Juno Diagnostics™ (JunoDx™), a company focused on bringing vital health information to patients by improving access, affordability, and...

up-and-comer has keyed in on a rising star in the biotech world. Ellen Hukkelhoven, an analyst at $8.8 billion Perceptive, presented at Wednesdays Sohn Conference about BridgeBio, the firms flagship hedge funds third biggest position, revealing how the company matched up "perfectly" with what Perceptive looks for in a biotech investment. Hukkelhoven, who has a doctorate in molecular biology, explained that the firm looks for companies where the science drives decisions, not the money. While it...

The round was led by the Perceptive Xontogeny Venture (PXV) Fund. The company intends to use the funds to support clinical validation studies, product development, and commercial launch of its product offerings for noninvasive prenatal testing (NIPT). Led by Dirk van den Boom, Founder and Chief Executive Officer, Mathias Ehrich M.D., Chief Scientific Officer, and Jim Chauvapun, Chief Operations Officer, Juno Diagnostics is developing genetic testing solutions to improve access to vital health ...

Nixxi Welcomes Haywood Brown, MD and Dirk van den Boom, PhD as New Advisory Board Members Share Article Nixxi, a women’s health company with a mission to improve pregnancy outcomes, is pleased to welcome two healthcare leaders to its advisory board. “We look forward to working with these leading experts in their fields, and continuing our commitment to providing innovative products to optimize pregnancy care.” PHOENIX (PRWEB) ...